Castres, France

Martial Grousseaud



 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2011-2014

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Martial Grousseaud: Innovator in Therapeutic Chemistry

Introduction

Martial Grousseaud is a notable inventor based in Castres, France. He has made significant contributions to the field of therapeutic chemistry, particularly in the development of anticancer agents. With a total of four patents to his name, Grousseaud's work is characterized by innovative processes that enhance the efficacy of therapeutic compounds.

Latest Patents

Grousseaud's latest patents include a process for the preparation of (poly) aminoalkylaminoacetamide derivatives of epipodophyllotoxin. This invention focuses on a new method that involves peptide coupling of 4-amino-4'-demethylepipodophyllotoxin with an amine-containing reactant. Another significant patent is a method for preparing 4B-amino-4'-demethyl-4-desoxypodophyllotoxin. This method outlines a series of steps for synthesizing the compound, emphasizing the reaction of thiourea with specific derivatives of podophyllotoxin.

Career Highlights

Throughout his career, Grousseaud has worked with prominent companies, including Pierre Fabre Medicament. His expertise in therapeutic chemistry has allowed him to develop innovative solutions that address critical health challenges.

Collaborations

Grousseaud has collaborated with notable colleagues such as Yves Guminski and Thierry Imbert. These partnerships have contributed to the advancement of his research and the successful development of his patented processes.

Conclusion

Martial Grousseaud stands out as a significant figure in the field of therapeutic chemistry, with a focus on anticancer agents. His innovative patents and collaborations reflect his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…